"It is a great honor to be included together with all the Athos co-founders in Stanford's prestigious list of the world's top 2% of scientists," said Dimitrios Iliopoulos, PhD, MBA, Co-Founder, ...
ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related to induced Treg anti-inflammatory ...
REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- ATHOS, a leading innovator in next generation wearable sensors and performance apparel, announced today that it has closed $12.2 million in Series B financing.
The Athos drug development platform begins with over 25,000 high-quality patient samples sourced from premier global hospital systems. Athos' AI 2 platform identifies novel drug targets by integrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results